Lupin facility in MP gets European body’s approval for medicine quality

PTI New Delhi | Updated on July 30, 2018 Published on July 30, 2018

Drug firm Lupin today said it has received attestation from the European Directorate for the Quality of Medicines (EDQM) for its Mandideep facility in Madhya Pradesh. The unit was inspected by EDQM in March this year, Lupin said in a statement.

“The inspection was focused on the application for certificate of suitability for the dossier of Cefaclor, along with facility inspection for Quality Management Systems based on cGMP, as laid under European Union rules governing medicinal products,” it added.

Lupin MD Nilesh Gupta said: “We are happy to receive the EDQM attestation for our Mandideep facility.” Over the past few months, Lupin has continued to drive multiple initiatives to further strengthen manufacturing standards and best practices to be amongst the best, he added.

The Lupin stock was trading 1.53 per cent up at Rs 827.90 on BSE in the afternoon.

Published on July 30, 2018
This article is closed for comments.
Please Email the Editor